Evermay Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.51K Hold
50
﹤0.01% 513
2026
Q1
$8.44K Hold
50
﹤0.01% 474
2025
Q4
$8.44K Hold
50
﹤0.01% 460
2025
Q3
$7.22K Hold
50
﹤0.01% 461
2025
Q2
$6.33K Hold
50
﹤0.01% 469
2025
Q1
$6.39K Hold
50
﹤0.01% 473
2024
Q4
$6.61K Hold
50
﹤0.01% 475
2024
Q3
$7.28K Hold
50
﹤0.01% 482
2024
Q2
$6.86K Hold
50
﹤0.01% 480
2024
Q1
$6.86K Hold
50
﹤0.01% 491
2023
Q4
$6.79K Hold
50
﹤0.01% 471
2023
Q3
$6.12K Hold
50
﹤0.01% 459
2023
Q2
$6.35K Hold
50
﹤0.01% 454
2023
Q1
$6.46K Hold
50
﹤0.01% 446
2022
Q4
$6.56K Sell
50
-58
-54% -$7.5K ﹤0.01% 444
2022
Q3
$13K Hold
108
﹤0.01% 373
2022
Q2
$13K Sell
108
-75
-41% -$8.9K ﹤0.01% 374
2022
Q1
$24K Hold
183
﹤0.01% 354
2021
Q4
$28K Buy
183
+50
+38% +$7.74K 0.01% 332
2021
Q3
$22K Hold
133
﹤0.01% 327
2021
Q2
$22K Buy
+133
New +$20.5K ﹤0.01% 351

Other funds holding IBB

Evermay Wealth Management's IBB Position: Q2 2026 in Review

Evermay Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 50 shares worth $9.51K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Evermay Wealth Management first reported a position in IBB in Q2 2021 and has held it in 21 quarters since. The position peaked at $28K in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Evermay Wealth Management held 50 shares of iShares Biotechnology ETF worth $9.51K as of Q2 2026.
  • Evermay Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #513 holding.
  • Evermay Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 21 quarters since.
  • Evermay Wealth Management's iShares Biotechnology ETF position peaked at $28K in Q4 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.